Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct:144 Pt A:172-9.
doi: 10.1016/j.jsbmb.2013.10.016. Epub 2013 Oct 31.

25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes

Affiliations
Review

25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes

Amy E Riek et al. J Steroid Biochem Mol Biol. 2014 Oct.

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality in patients with type 2 diabetes mellitus (T2DM). Vitamin D deficiency is not only more prevalent in diabetics but also doubles the risk of developing CVD. However, it is unknown whether 25-hydroxy vitamin D [25(OH)D3] replacement slows monocyte adhesion and migration, critical mechanisms involved in atherosclerosis progression. In this study, monocytes from vitamin D-deficient diabetic patients were cultured either in the patient's serum or in vitamin D-deficient media with or without 25(OH)D3 treatment. Adding 25(OH)D3 to monocytes cultured in vitamin D-deficient serum or media decreased monocyte adhesion to fibronectin and migration stimulated by monocyte chemotactic protein 1 (MCP-1). Accordingly, 25(OH)D3 decreased adhesion marker β1- and β2-integrin expression and migration receptor chemokine (C-C motif) receptor 2 (CCR2) expression. 25(OH)D3 treatment downregulated monocyte endoplasmic reticulum (ER) stress and scavenger receptor class A, type 1 (SR-A1) expression. The absence of SR-A1 prevented the increased macrophage adhesion and migration induced by vitamin D deficiency. Moreover, the absence of SR-A1 prevented the induction of adhesion and migration and expression of their associated membrane receptors by Thapsigargin, an ER stress inducer. These results identify cellular activation of monocyte/macrophage vitamin D signaling through 25(OH)D3 as a potential mechanism that could modulate adhesion and migration in diabetic subjects. This article is part of a Special Issue entitled '16th Vitamin D Workshop'.

Keywords: Adhesion; Diabetes; Macrophage; Migration; SR-A1; Vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1. 25(OH)D3 suppresses monocyte adhesion in type 2 diabetics
For A–C, monocytes from vitamin D-deficient type 2 diabetics were cultured in vitamin D-deficient or 25(OH)D3-treated patient serum. A. Adhesion assay showing absorbance of cells adhered to fibronectin (n=12, *p<0.05 vs. vitamin D-deficient). B–C. qPCR for mRNA of adhesion receptors B. β1-integrin and C. β2-integrin (n=6, *p<0.001 for both vs. vitamin D-deficient). For D–F, monocytes from vitamin D-deficient type 2 diabetics were cultured in vitamin D-deficient or 25(OH)D3-treated media. D. Adhesion assay showing absorbance of cells adhered to fibronectin (n=12, *p<0.001 vs. vitamin D-deficient). E–F. qPCR for mRNA of adhesion receptors E. β1-integrin and F. β2-integrin (n=6, *p<0.01 for both vs. vitamin D-deficient).
Figure 2
Figure 2. 25(OH)D3 suppresses monocyte migration in type 2 diabetics
Transwell migration assays in monocytes from vitamin D-deficient type 2 diabetics cultured in A. vitamin D-deficient or 25(OH)D3-treated patient serum (n=12, *p<0.001 vs. vitamin D-deficient) and B. vitamin D-deficient or 25(OH)D3-treated media (n=12, *p<0.005 vs. vitamin D-deficient). C–D. qPCR for mRNA of CCR2 from monocytes from vitamin D-deficient type 2 diabetics cultured inC. vitamin D-deficient or 25(OH)D3-treated patient serum and D. vitamin D-deficient or 25(OH)D3-treated media (n=6, *p<0.001 for both vs. vitamin D-deficient).
Figure 3
Figure 3. 25(OH)D3 suppresses monocyte ER stress in type 2 diabetics
Monocytes from vitamin D-deficient type 2 diabetics were cultured in vitamin D-deficient or 25(OH)D3-treated patient serum or media. Western blot for protein expression of scavenger receptor SR-A1 and ER stress proteins p-PERK, p-IRE1α, and CHOP.
Figure 4
Figure 4. SR-A1 knockout suppresses macrophage adhesion and migration induced by vitamin D deficiency
Peritoneal macrophages were isolated from WT and SR-A1−/− mice after normal saline injection and cultured in vitamin D-deficient or 25(OH)D3-treated media. A. Adhesion assay showing absorbance of cells adhered to fibronectin (n=4 per group, p<0.001 by ANOVA, *p<0.05 vs. all other groups by Tukey’s post-test). B. Transwell migration assay (n=4 per group, p<0.005 by ANOVA, *p<0.05 vs. all other groups by Tukey’s post-test). C– E. qPCR for mRNA of adhesion receptors C. β1-integrin and D. β2-integrin and E. migration receptor CCR2 (n=3 per group, p<0.01 by ANOVA for each, *p<0.05 vs. all other groups by Tukey’s post-test).
Figure 5
Figure 5. SR-A1 knockout suppresses macrophage adhesion and migration induced by ER stress
Peritoneal macrophages were isolated from WT and SR-A1−/− mice after normal saline injection and cultured in 25(OH)D3-treated media with or without Thapsigargin. A. Adhesion assay showing absorbance of cells adhered to fibronectin (n=4 per group, p<0.001 by ANOVA, *p<0.05 vs. all other groups by Tukey’s post-test). B. Transwell migration assay (n=4 per group, p<0.001 by ANOVA, *p<0.05 vs. all other groups by Tukey’s post-test, **p<0.05 between indicated groups by Tukey’s post-test). C–E. qPCR for mRNA of adhesion receptors C. β1-integrin and D. β2-integrin and E. migration receptor CCR2 (n=3 per group, p<0.005 by ANOVA for each, *p<0.05 vs. all other groups by Tukey’s post-test).

Similar articles

Cited by

References

    1. National diabetes fact sheet: general information and national estimates on diabetes in the United States. Centers for Disease Control and Prevention; 2011. pp. 1–12.
    1. National Diabetes Statistics; N.I.o. Health, editor. NIH publication 08-3892. 2007. pp. 1–24.
    1. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL. Innate and acquired immunity in atherogenesis. Nat Med. 2002;8(11):1218–1226. - PubMed
    1. Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233–241. - PMC - PubMed
    1. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–355. - PMC - PubMed

Publication types

MeSH terms